AR085817A1 - Derivados de isoxazolidina - Google Patents

Derivados de isoxazolidina

Info

Publication number: AR085817A1
Authority: AR; Argentina
Prior art keywords: alkyl; group; branched; linear; cycloalkyl
Prior art date: 2011-03-15

Application number

ARP120100843A

Other languages

English (en)

Spanish (es)

Inventor

Eleonora Ghidini

Andrea Rizzi

Original Assignee

Chiesi Farma Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-03-15

Filing date

2012-03-14

Publication date

2013-10-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44351355&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR085817(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2012-03-14 Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa

2013-10-30 Publication of AR085817A1 publication Critical patent/AR085817A1/es

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0036—Nitrogen-containing hetero ring
- C07J71/0057—Nitrogen and oxygen
- C07J71/0068—Nitrogen and oxygen at position 16(17)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Medicinal Preparation (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

ARP120100843A 2011-03-15 2012-03-14 Derivados de isoxazolidina AR085817A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP11158230		2011-03-15

Publications (1)

Publication Number	Publication Date
AR085817A1 true AR085817A1 (es)	2013-10-30

Family

ID=44351355

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ARP120100843A AR085817A1 (es)	2011-03-15	2012-03-14	Derivados de isoxazolidina

Country Status (23)

Country	Link
US (3)	US20120234316A1 (ja)
EP (2)	EP2686332A2 (ja)
JP (1)	JP6053700B2 (ja)
KR (1)	KR101956937B1 (ja)
CN (1)	CN103391945B (ja)
AR (1)	AR085817A1 (ja)
AU (1)	AU2012228334B2 (ja)
BR (1)	BR112013023539B1 (ja)
CA (1)	CA2850081C (ja)
CL (1)	CL2013002629A1 (ja)
EA (1)	EA028904B1 (ja)
GE (1)	GEP201606566B (ja)
IL (1)	IL228382A (ja)
MX (1)	MX345400B (ja)
MY (1)	MY194140A (ja)
PE (1)	PE20140890A1 (ja)
PH (1)	PH12013501813A1 (ja)
SG (1)	SG193262A1 (ja)
TN (1)	TN2013000313A1 (ja)
TW (1)	TWI658047B (ja)
UA (1)	UA113508C2 (ja)
WO (1)	WO2012123482A2 (ja)
ZA (2)	ZA201306881B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN103814043A (zh)	2011-08-01	2014-05-21	奇斯药制品公司	在16，17位与吡咯烷环稠合的抗炎类固醇
US9155747B2 (en) *	2012-09-13	2015-10-13	Chiesi Farmaceutici S.P.A.	Isoxazolidine derivatives
EP2902382A1 (en) *	2014-01-30	2015-08-05	Fundació Institut de Recerca Biomèdica IRB (Barcelona)	Primary hydroxylamines and uses thereof
SI3662910T1 (sl) *	2014-03-31	2025-05-30	The Scripps Research Institute	Farmakofor za induciranje TRAIL
CN113332439A (zh)	2014-09-03	2021-09-03	理森制药股份公司	包含双重PI3Kδ-γ激酶抑制剂和皮质类固醇的治疗方法及组合物
CN104262440B (zh) *	2014-09-10	2016-08-17	江西赣亮医药原料有限公司	一种16ɑ-羟基泼尼松龙的制备方法
CN117050128A (zh) *	2023-08-15	2023-11-14	黄冈人福药业有限责任公司	一种11β-羟基-孕甾-1,4,16-三烯-3,20-二酮-21-醋酸酯的制备方法和设备
CN118638008B (zh) *	2024-08-14	2024-12-17	淄博飞源化工有限公司	甲基丙烯酸三氟乙酯及其合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL31997A (en) *	1968-05-03	1974-03-14	Lepetit Spa	Process for the preparation of pregnano(17alpha,16alpha-d)oxazolines and 16alpha,21-dihydroxy-17alpha-aminopregnanes
US4018774A (en)	1976-02-13	1977-04-19	E. R. Squibb & Sons, Inc.	Steroidal [16α,17-d]isoxazolidines
AR224124A1 (es) *	1978-04-05	1981-10-30	Syntex Inc	Procedimiento para preparar 4-halo-pregna-1,4-dieno-3,20-dionas
WO2005028495A1 (en) *	2003-09-24	2005-03-31	Glaxo Group Limited	Anti-inflammatory glucocorticoids
GB0415747D0 (en) *	2004-07-14	2004-08-18	Novartis Ag	Organic compounds
JP2008526776A (ja)	2005-01-03	2008-07-24	ミリアドジェネティクス，インコーポレイテッド	脳癌の治療の方法
EA201070535A1 (ru) *	2007-11-30	2010-12-30	Пфайзер Лимитед	Новые агонисты глюкокортикоидных рецепторов
WO2009108118A1 (en) *	2008-02-27	2009-09-03	Astrazeneca Ab	16 alpha, 17 alpa-acetal glucocorticosteroidal derivatives and their use
CN101926805A (zh) *	2009-06-24	2010-12-29	天津金耀集团有限公司	一种含有16,17异恶唑烷类甾体化合物的药物组合物
PE20120894A1 (es) *	2009-09-11	2012-08-13	Chiesi Farma Spa	Derivados de isoxazolidina
TW201139369A (en) *	2010-02-05	2011-11-16	Chiesi Farma Spa	Pyrrolidine derivatives
KR20140039161A (ko)	2011-03-15	2014-04-01	키에시 파르마슈티시 엣스. 피. 에이.	이소옥사졸리딘 유도체
CN103814043A (zh)	2011-08-01	2014-05-21	奇斯药制品公司	在16，17位与吡咯烷环稠合的抗炎类固醇
US9155747B2 (en)	2012-09-13	2015-10-13	Chiesi Farmaceutici S.P.A.	Isoxazolidine derivatives

2012
- 2012-03-14 EP EP12711601.0A patent/EP2686332A2/en not_active Withdrawn
- 2012-03-14 JP JP2013558416A patent/JP6053700B2/ja not_active Expired - Fee Related
- 2012-03-14 EA EA201391173A patent/EA028904B1/ru not_active IP Right Cessation
- 2012-03-14 EP EP13197855.3A patent/EP2716648B1/en active Active
- 2012-03-14 CN CN201280008928.3A patent/CN103391945B/zh not_active Expired - Fee Related
- 2012-03-14 BR BR112013023539-0A patent/BR112013023539B1/pt not_active IP Right Cessation
- 2012-03-14 TW TW101108588A patent/TWI658047B/zh not_active IP Right Cessation
- 2012-03-14 UA UAA201310933A patent/UA113508C2/uk unknown
- 2012-03-14 KR KR1020137022976A patent/KR101956937B1/ko not_active Expired - Fee Related
- 2012-03-14 PE PE2013002015A patent/PE20140890A1/es active IP Right Grant
- 2012-03-14 AU AU2012228334A patent/AU2012228334B2/en not_active Ceased
- 2012-03-14 MX MX2013010354A patent/MX345400B/es active IP Right Grant
- 2012-03-14 PH PH1/2013/501813A patent/PH12013501813A1/en unknown
- 2012-03-14 CA CA2850081A patent/CA2850081C/en active Active
- 2012-03-14 SG SG2013065974A patent/SG193262A1/en unknown
- 2012-03-14 WO PCT/EP2012/054439 patent/WO2012123482A2/en not_active Ceased
- 2012-03-14 AR ARP120100843A patent/AR085817A1/es active IP Right Grant
- 2012-03-14 GE GEAP201213223A patent/GEP201606566B/en unknown
- 2012-03-14 MY MYPI2013002925A patent/MY194140A/en unknown
- 2012-03-15 US US13/421,150 patent/US20120234316A1/en not_active Abandoned
2013
- 2013-07-24 TN TNP2013000313A patent/TN2013000313A1/fr unknown
- 2013-09-12 ZA ZA2013/06881A patent/ZA201306881B/en unknown
- 2013-09-12 CL CL2013002629A patent/CL2013002629A1/es unknown
- 2013-09-12 IL IL228382A patent/IL228382A/en active IP Right Grant
2014
- 2014-07-31 ZA ZA2014/05681A patent/ZA201405681B/en unknown
- 2014-11-10 US US14/537,184 patent/US9845337B2/en not_active Expired - Fee Related
2017
- 2017-11-08 US US15/807,066 patent/US10280193B2/en active Active

Also Published As

Publication number	Publication date
TN2013000313A1 (en)	2015-01-20
PH12013501813A1 (en)	2013-10-14
KR20140006016A (ko)	2014-01-15
TW201247697A (en)	2012-12-01
IL228382A (en)	2017-08-31
MY194140A (en)	2022-11-14
MX345400B (es)	2017-01-30
TWI658047B (zh)	2019-05-01
ZA201306881B (en)	2014-11-26
CA2850081A1 (en)	2012-09-20
IL228382A0 (en)	2013-12-31
AU2012228334A1 (en)	2013-10-03
EA028904B1 (ru)	2018-01-31
US20120234316A1 (en)	2012-09-20
MX2013010354A (es)	2013-12-06
EP2686332A2 (en)	2014-01-22
NZ615423A (en)	2015-08-28
WO2012123482A2 (en)	2012-09-20
EP2716648B1 (en)	2017-06-14
JP2014508181A (ja)	2014-04-03
AU2012228334B2 (en)	2017-03-23
CN103391945A (zh)	2013-11-13
BR112013023539A2 (pt)	2017-01-24
UA113508C2 (xx)	2017-02-10
ZA201405681B (en)	2015-12-23
EA201391173A1 (ru)	2014-01-30
GEP201606566B (en)	2016-11-10
US20150057257A1 (en)	2015-02-26
SG193262A1 (en)	2013-10-30
EP2716648A1 (en)	2014-04-09
US10280193B2 (en)	2019-05-07
JP6053700B2 (ja)	2016-12-27
CN103391945B (zh)	2016-11-09
CA2850081C (en)	2020-01-07
US20180066010A1 (en)	2018-03-08
PE20140890A1 (es)	2014-08-05
US9845337B2 (en)	2017-12-19
KR101956937B1 (ko)	2019-03-11
CL2013002629A1 (es)	2014-01-10
WO2012123482A3 (en)	2013-02-07
BR112013023539B1 (pt)	2022-03-03

Publication	Publication Date	Title
AR085817A1 (es)	2013-10-30	Derivados de isoxazolidina
AR114941A1 (es)	2020-11-11	Derivados de sulfonilurea
UY37513A (es)	2018-07-31	Modulador del regulador de conductancia transmembrana de fibrosis quística, composiciones farmacéuticas, métodos de tratamiento y proceso para producir el modulador
ES2722048T3 (es)	2019-08-07	Compuestos de triazolopirimidina y usos de los mismos
AR078164A1 (es)	2011-10-19	Derivados de isoxazolidina, proceso para preparar dichos compuestos y composiciones farmaceuticas que los comprenden
ES2770058T3 (es)	2020-06-30	Compuestos y composiciones destinados a modular las actividades de quinasa de EGFR mutante
AR093832A1 (es)	2015-06-24	COMPUESTOS CON ACTIVIDAD ANTAGONISTA DE LOS RECEPTORES MUSCARINICOS Y ACTIVIDAD AGONISTA DEL RECEPTOR b2 ADRENERGICO
MX381707B (es)	2025-03-13	Nuevos derivados biciclicos, un proceso para su preparacion y composiciones farmaceuticas que los contienen.
SV2016005229A (es)	2017-07-28	Inhibidores de syk
UY31524A1 (es)	2009-08-03	Nuevos compuestos 010
UY33921A (es)	2012-09-28	Oxazinopteridinas y oxazinoptiridinonas n-sustituidas
AR113909A1 (es)	2020-06-24	Compuestos y sus composiciones farmacéuticas para el tratamiento de hepatitis b
AR052948A1 (es)	2007-04-11	DERIVADOS DE ACETILENIL-PIRAZOLO-PIRIMIDINA COMO ANTAGONISTAS DE MGLUR2, METODOS PARA SU PREPARACION, COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN Y SU EMPLEO EN LA FABRICACIoN DE UN MEDICAMENTO PARA EL TRATAMIENTO DE ENFERMEDADES DEL SNC
AR082699A1 (es)	2012-12-26	Sales de fenotiazindiaminio, composicion farmaceutica en base al compuesto y proceso de preparacion del compuesto
PE20151860A1 (es)	2015-12-16	Derivados de 6-(5-hidroxi-1h-pirazol-1-il)nicotinamida y su uso como inhidores de la phd
CR20140548A (es)	2015-02-12	Derivados de aril-sultamo como moduladores de rorc
AR079689A1 (es)	2012-02-15	Derivados de imidazo[1,2a]piridina, composiciones farmaceuticas que los comprenden y uso de los mismos en trastornos mieloproliferativos, leucemia y enfermedades inmunologicas e inflamatorias.
AR062677A1 (es)	2008-11-26	Derivados de biaril-sulfonamida, procesos de produccion y composiciones farmaceuticas que los comprenden
CO6700838A2 (es)	2013-06-28	Compuestos sustituidos de banzamida
AR078641A1 (es)	2011-11-23	Amidas sustituidas con halogenoalquilo como insecticidas y acaricidas
AR109829A1 (es)	2019-01-30	Derivados de piperidina puenteados
AR103742A1 (es)	2017-05-31	Derivados de trifluorometilpropanamida
ES2584556T3 (es)	2016-09-28	Composiciones novedosas que contienen carbodiimida, un procedimiento para su preparación y su uso
AR081966A1 (es)	2012-10-31	Derivados aminoester de alcaloides y composicion medicinal de los mismos
AR101222A1 (es)	2016-11-30	Derivados de piridona

Legal Events

Date	Code	Title	Description
2022-07-29	FG	Grant, registration